Giovanna Brunasso

14PUBLICATIONS
70CO-AUTHORS
AllergyEpidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseasePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Feb 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).

Diego Orsini, Dario Graceffa, Martina Burlando

|Jan 11, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis.

Francesca Prignano, Giuseppe Argenziano, Federico Bardazzi

|Jun 28, 2023
Risankizumab: Daily Practice Experience of High Need Patients.

Alexandra M G Brunasso, Martina Burlando, Fabrizio Amoruso

|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing.

Francesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini

Pageof 3

Frequent Collaborators

5 joint publications

Cesare Massone

4 joint publications

Maria Concetta Fargnoli

3 joint publications

Giampiero Girolomoni

3 joint publications

Maria Esposito